🚀 Pharmidex Unveils Its Cutting-Edge In Silico Drug Discovery Platform! 🧬💻
February 24, 2025

At Pharmidex, we are revolutionizing drug discovery with our state-of-the-art in silico platform (https://lnkd.in/eibfwguP), accelerating the path from target identification to lead optimization with precision and efficiency.

🔬 What sets our platform apart?
✅ AI-driven target identification & protein structure analysis
✅ Advanced molecular docking for high-affinity ligand screening
✅ 3D pharmacophore modeling for enhanced drug design
✅ Seamless integration of predictive simulations & real-world validation

Our approach combines cutting-edge computational tools with deep scientific expertise to de-risk drug development and fast-track novel therapeutics for a healthier future.

📽️ Watch our latest video(1/5) showcasing the power of our technology, starting from Determination of target structures and Determination of ligands

📩 Ready to transform your drug discovery journey? Let’s collaborate!

December 16, 2025
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
More Posts